retatrutide side effects phase 2 trial Triple Agonist Associated with Weight Loss of up to 24% in 48-Week retatrutide clinical trial safety data

Imagine a world where staying healthier is easier than staying unhealthy

GLP-1 medications do not appear to worsen autoimmune thyroid inflammation

Contraindications Absolute contraindications I never compromise on: Current opioid medication use (LDN will block their effectiveness) Severe liver disease Pregnancy and breastfeeding (insufficient safety data) Relative contraindications requiring careful consideration: Organ transplant recipients taking immunosuppressive medications Active cancer treatment How I Monitor Success Success with Low Dose Naltrexone encompasses both measurable improvements and patient-reported changes: What I track: Reduced inflammatory markers (ESR, CRP), improved functional scores, decreased need for pain medications

What took decades to accumulate - sun damage, glycation, natural collagen decline - will not reverse in six weeks of aggressive treatment

New work demonstrates how one antioxidant inside particular cellular compartments, the mitochondrial metabolite glutathione, helps cancer cells metastasize throughout the body by enabling their survival under low-oxygen conditions